0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intrauterine Contraceptive Market Insights, Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-9L6740
Home | Market Reports | Health | Reproductive Health
Global Intrauterine Contraceptive Market Insights Forecast to 2028

Global Intrauterine Contraceptive Market Insights, Forecast to 2028

Code: QYRE-Auto-9L6740
Report
January 2022
88 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
An intrauterine contraceptive device is a medical device, which is inserted in the uterus to prevent conception. A plastic string is attached to the end of the device to ensure correct placement and its removal. These devices are available in various forms, such as coil, loop, triangle, and T-shaped, and are made up of plastic or metal. An intrauterine contraceptive device may also be used as an emergency contraception method after unprotected sex. An intrauterine contraceptive device is inserted into the uterus with the help of health care professionals.
Market Analysis and Insights: Global Intrauterine Contraceptive Market

Due to the COVID-19 pandemic, the global Intrauterine Contraceptive market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Nonhormonal Intrauterine Contraceptive Devices accounting for % of the Intrauterine Contraceptive global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.
Increasing prevalence of unplanned pregnancies, less side-effects associated with intrauterine contraceptive devices, and implementation of affordable care are some of the key factors driving the growth of the global intrauterine contraceptive device market. In addition, increasing awareness about pregnancy is also driving the growth of the global intrauterine contraceptive device market.
Global Intrauterine Contraceptive Scope and Segment
Intrauterine Contraceptive market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Intrauterine Contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Nonhormonal Intrauterine Contraceptive Devices
Hormonal Intrauterine Contraceptive Devices

Segment by Application

Hospitals
Community Health Care Centers
Others

BY COMPANY

DKT International
Melbea AG
Pregna International Limited
Ocon Medical Ltd
SMB Corporation of India
Mona Lisa N.V.

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Intrauterine Contraceptive Product Introduction
1.2 Market by Type
1.2.1 Global Intrauterine Contraceptive Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Nonhormonal Intrauterine Contraceptive Devices
1.2.3 Hormonal Intrauterine Contraceptive Devices
1.3 Market by Application
1.3.1 Global Intrauterine Contraceptive Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Community Health Care Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intrauterine Contraceptive Sales Estimates and Forecasts 2017-2028
2.2 Global Intrauterine Contraceptive Revenue Estimates and Forecasts 2017-2028
2.3 Global Intrauterine Contraceptive Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Intrauterine Contraceptive Sales by Region
2.4.1 Global Intrauterine Contraceptive Sales by Region (2017-2022)
2.4.2 Global Sales Intrauterine Contraceptive by Region (2023-2028)
2.5 Global Intrauterine Contraceptive Revenue by Region
2.5.1 Global Intrauterine Contraceptive Revenue by Region (2017-2022)
2.5.2 Global Intrauterine Contraceptive Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Intrauterine Contraceptive Sales by Manufacturers
3.1.1 Global Top Intrauterine Contraceptive Manufacturers by Sales (2017-2022)
3.1.2 Global Intrauterine Contraceptive Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intrauterine Contraceptive in 2021
3.2 Global Intrauterine Contraceptive Revenue by Manufacturers
3.2.1 Global Intrauterine Contraceptive Revenue by Manufacturers (2017-2022)
3.2.2 Global Intrauterine Contraceptive Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Intrauterine Contraceptive Revenue in 2021
3.3 Global Intrauterine Contraceptive Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Intrauterine Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Intrauterine Contraceptive Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intrauterine Contraceptive Sales by Type
4.1.1 Global Intrauterine Contraceptive Historical Sales by Type (2017-2022)
4.1.2 Global Intrauterine Contraceptive Forecasted Sales by Type (2023-2028)
4.1.3 Global Intrauterine Contraceptive Sales Market Share by Type (2017-2028)
4.2 Global Intrauterine Contraceptive Revenue by Type
4.2.1 Global Intrauterine Contraceptive Historical Revenue by Type (2017-2022)
4.2.2 Global Intrauterine Contraceptive Forecasted Revenue by Type (2023-2028)
4.2.3 Global Intrauterine Contraceptive Revenue Market Share by Type (2017-2028)
4.3 Global Intrauterine Contraceptive Price by Type
4.3.1 Global Intrauterine Contraceptive Price by Type (2017-2022)
4.3.2 Global Intrauterine Contraceptive Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Intrauterine Contraceptive Sales by Application
5.1.1 Global Intrauterine Contraceptive Historical Sales by Application (2017-2022)
5.1.2 Global Intrauterine Contraceptive Forecasted Sales by Application (2023-2028)
5.1.3 Global Intrauterine Contraceptive Sales Market Share by Application (2017-2028)
5.2 Global Intrauterine Contraceptive Revenue by Application
5.2.1 Global Intrauterine Contraceptive Historical Revenue by Application (2017-2022)
5.2.2 Global Intrauterine Contraceptive Forecasted Revenue by Application (2023-2028)
5.2.3 Global Intrauterine Contraceptive Revenue Market Share by Application (2017-2028)
5.3 Global Intrauterine Contraceptive Price by Application
5.3.1 Global Intrauterine Contraceptive Price by Application (2017-2022)
5.3.2 Global Intrauterine Contraceptive Price Forecast by Application (2023-2028)
6 North America
6.1 North America Intrauterine Contraceptive Market Size by Type
6.1.1 North America Intrauterine Contraceptive Sales by Type (2017-2028)
6.1.2 North America Intrauterine Contraceptive Revenue by Type (2017-2028)
6.2 North America Intrauterine Contraceptive Market Size by Application
6.2.1 North America Intrauterine Contraceptive Sales by Application (2017-2028)
6.2.2 North America Intrauterine Contraceptive Revenue by Application (2017-2028)
6.3 North America Intrauterine Contraceptive Market Size by Country
6.3.1 North America Intrauterine Contraceptive Sales by Country (2017-2028)
6.3.2 North America Intrauterine Contraceptive Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Intrauterine Contraceptive Market Size by Type
7.1.1 Europe Intrauterine Contraceptive Sales by Type (2017-2028)
7.1.2 Europe Intrauterine Contraceptive Revenue by Type (2017-2028)
7.2 Europe Intrauterine Contraceptive Market Size by Application
7.2.1 Europe Intrauterine Contraceptive Sales by Application (2017-2028)
7.2.2 Europe Intrauterine Contraceptive Revenue by Application (2017-2028)
7.3 Europe Intrauterine Contraceptive Market Size by Country
7.3.1 Europe Intrauterine Contraceptive Sales by Country (2017-2028)
7.3.2 Europe Intrauterine Contraceptive Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intrauterine Contraceptive Market Size by Type
8.1.1 Asia Pacific Intrauterine Contraceptive Sales by Type (2017-2028)
8.1.2 Asia Pacific Intrauterine Contraceptive Revenue by Type (2017-2028)
8.2 Asia Pacific Intrauterine Contraceptive Market Size by Application
8.2.1 Asia Pacific Intrauterine Contraceptive Sales by Application (2017-2028)
8.2.2 Asia Pacific Intrauterine Contraceptive Revenue by Application (2017-2028)
8.3 Asia Pacific Intrauterine Contraceptive Market Size by Region
8.3.1 Asia Pacific Intrauterine Contraceptive Sales by Region (2017-2028)
8.3.2 Asia Pacific Intrauterine Contraceptive Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Intrauterine Contraceptive Market Size by Type
9.1.1 Latin America Intrauterine Contraceptive Sales by Type (2017-2028)
9.1.2 Latin America Intrauterine Contraceptive Revenue by Type (2017-2028)
9.2 Latin America Intrauterine Contraceptive Market Size by Application
9.2.1 Latin America Intrauterine Contraceptive Sales by Application (2017-2028)
9.2.2 Latin America Intrauterine Contraceptive Revenue by Application (2017-2028)
9.3 Latin America Intrauterine Contraceptive Market Size by Country
9.3.1 Latin America Intrauterine Contraceptive Sales by Country (2017-2028)
9.3.2 Latin America Intrauterine Contraceptive Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Intrauterine Contraceptive Market Size by Type
10.1.1 Middle East and Africa Intrauterine Contraceptive Sales by Type (2017-2028)
10.1.2 Middle East and Africa Intrauterine Contraceptive Revenue by Type (2017-2028)
10.2 Middle East and Africa Intrauterine Contraceptive Market Size by Application
10.2.1 Middle East and Africa Intrauterine Contraceptive Sales by Application (2017-2028)
10.2.2 Middle East and Africa Intrauterine Contraceptive Revenue by Application (2017-2028)
10.3 Middle East and Africa Intrauterine Contraceptive Market Size by Country
10.3.1 Middle East and Africa Intrauterine Contraceptive Sales by Country (2017-2028)
10.3.2 Middle East and Africa Intrauterine Contraceptive Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 DKT International
11.1.1 DKT International Corporation Information
11.1.2 DKT International Overview
11.1.3 DKT International Intrauterine Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 DKT International Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 DKT International Recent Developments
11.2 Melbea AG
11.2.1 Melbea AG Corporation Information
11.2.2 Melbea AG Overview
11.2.3 Melbea AG Intrauterine Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Melbea AG Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Melbea AG Recent Developments
11.3 Pregna International Limited
11.3.1 Pregna International Limited Corporation Information
11.3.2 Pregna International Limited Overview
11.3.3 Pregna International Limited Intrauterine Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pregna International Limited Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pregna International Limited Recent Developments
11.4 Ocon Medical Ltd
11.4.1 Ocon Medical Ltd Corporation Information
11.4.2 Ocon Medical Ltd Overview
11.4.3 Ocon Medical Ltd Intrauterine Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ocon Medical Ltd Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ocon Medical Ltd Recent Developments
11.5 SMB Corporation of India
11.5.1 SMB Corporation of India Corporation Information
11.5.2 SMB Corporation of India Overview
11.5.3 SMB Corporation of India Intrauterine Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 SMB Corporation of India Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 SMB Corporation of India Recent Developments
11.6 Mona Lisa N.V.
11.6.1 Mona Lisa N.V. Corporation Information
11.6.2 Mona Lisa N.V. Overview
11.6.3 Mona Lisa N.V. Intrauterine Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Mona Lisa N.V. Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mona Lisa N.V. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intrauterine Contraceptive Industry Chain Analysis
12.2 Intrauterine Contraceptive Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intrauterine Contraceptive Production Mode & Process
12.4 Intrauterine Contraceptive Sales and Marketing
12.4.1 Intrauterine Contraceptive Sales Channels
12.4.2 Intrauterine Contraceptive Distributors
12.5 Intrauterine Contraceptive Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Intrauterine Contraceptive Industry Trends
13.2 Intrauterine Contraceptive Market Drivers
13.3 Intrauterine Contraceptive Market Challenges
13.4 Intrauterine Contraceptive Market Restraints
14 Key Findings in The Global Intrauterine Contraceptive Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Intrauterine Contraceptive Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Nonhormonal Intrauterine Contraceptive Devices
    Table 3. Major Manufacturers of Hormonal Intrauterine Contraceptive Devices
    Table 4. Global Intrauterine Contraceptive Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Intrauterine Contraceptive Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Intrauterine Contraceptive Sales by Region (2017-2022) & (K Units)
    Table 7. Global Intrauterine Contraceptive Sales Market Share by Region (2017-2022)
    Table 8. Global Intrauterine Contraceptive Sales by Region (2023-2028) & (K Units)
    Table 9. Global Intrauterine Contraceptive Sales Market Share by Region (2023-2028)
    Table 10. Global Intrauterine Contraceptive Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Intrauterine Contraceptive Revenue Market Share by Region (2017-2022)
    Table 12. Global Intrauterine Contraceptive Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Intrauterine Contraceptive Revenue Market Share by Region (2023-2028)
    Table 14. Global Intrauterine Contraceptive Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Intrauterine Contraceptive Sales Share by Manufacturers (2017-2022)
    Table 16. Global Intrauterine Contraceptive Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Intrauterine Contraceptive Revenue Share by Manufacturers (2017-2022)
    Table 18. Intrauterine Contraceptive Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Intrauterine Contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Intrauterine Contraceptive by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intrauterine Contraceptive as of 2021)
    Table 21. Intrauterine Contraceptive Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Intrauterine Contraceptive Product Offered
    Table 23. Date of Manufacturers Enter into Intrauterine Contraceptive Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Intrauterine Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 26. Global Intrauterine Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 27. Global Intrauterine Contraceptive Sales Share by Type (2017-2022)
    Table 28. Global Intrauterine Contraceptive Sales Share by Type (2023-2028)
    Table 29. Global Intrauterine Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Intrauterine Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Intrauterine Contraceptive Revenue Share by Type (2017-2022)
    Table 32. Global Intrauterine Contraceptive Revenue Share by Type (2023-2028)
    Table 33. Intrauterine Contraceptive Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Intrauterine Contraceptive Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Intrauterine Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 36. Global Intrauterine Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 37. Global Intrauterine Contraceptive Sales Share by Application (2017-2022)
    Table 38. Global Intrauterine Contraceptive Sales Share by Application (2023-2028)
    Table 39. Global Intrauterine Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Intrauterine Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Intrauterine Contraceptive Revenue Share by Application (2017-2022)
    Table 42. Global Intrauterine Contraceptive Revenue Share by Application (2023-2028)
    Table 43. Intrauterine Contraceptive Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Intrauterine Contraceptive Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Intrauterine Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 46. North America Intrauterine Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 47. North America Intrauterine Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Intrauterine Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Intrauterine Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 50. North America Intrauterine Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 51. North America Intrauterine Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Intrauterine Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Intrauterine Contraceptive Sales by Country (2017-2022) & (K Units)
    Table 54. North America Intrauterine Contraceptive Sales by Country (2023-2028) & (K Units)
    Table 55. North America Intrauterine Contraceptive Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Intrauterine Contraceptive Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Intrauterine Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Intrauterine Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Intrauterine Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Intrauterine Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Intrauterine Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Intrauterine Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Intrauterine Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Intrauterine Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Intrauterine Contraceptive Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Intrauterine Contraceptive Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Intrauterine Contraceptive Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Intrauterine Contraceptive Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Intrauterine Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Intrauterine Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Intrauterine Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Intrauterine Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Intrauterine Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Intrauterine Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Intrauterine Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Intrauterine Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Intrauterine Contraceptive Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Intrauterine Contraceptive Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Intrauterine Contraceptive Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Intrauterine Contraceptive Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Intrauterine Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Intrauterine Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Intrauterine Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Intrauterine Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Intrauterine Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Intrauterine Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Intrauterine Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Intrauterine Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Intrauterine Contraceptive Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Intrauterine Contraceptive Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Intrauterine Contraceptive Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Intrauterine Contraceptive Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Intrauterine Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Intrauterine Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Intrauterine Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Intrauterine Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Intrauterine Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Intrauterine Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Intrauterine Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Intrauterine Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Intrauterine Contraceptive Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Intrauterine Contraceptive Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Intrauterine Contraceptive Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Intrauterine Contraceptive Revenue by Country (2023-2028) & (US$ Million)
    Table 105. DKT International Corporation Information
    Table 106. DKT International Description and Major Businesses
    Table 107. DKT International Intrauterine Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. DKT International Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. DKT International Recent Developments
    Table 110. Melbea AG Corporation Information
    Table 111. Melbea AG Description and Major Businesses
    Table 112. Melbea AG Intrauterine Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Melbea AG Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Melbea AG Recent Developments
    Table 115. Pregna International Limited Corporation Information
    Table 116. Pregna International Limited Description and Major Businesses
    Table 117. Pregna International Limited Intrauterine Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Pregna International Limited Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Pregna International Limited Recent Developments
    Table 120. Ocon Medical Ltd Corporation Information
    Table 121. Ocon Medical Ltd Description and Major Businesses
    Table 122. Ocon Medical Ltd Intrauterine Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Ocon Medical Ltd Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Ocon Medical Ltd Recent Developments
    Table 125. SMB Corporation of India Corporation Information
    Table 126. SMB Corporation of India Description and Major Businesses
    Table 127. SMB Corporation of India Intrauterine Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. SMB Corporation of India Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. SMB Corporation of India Recent Developments
    Table 130. Mona Lisa N.V. Corporation Information
    Table 131. Mona Lisa N.V. Description and Major Businesses
    Table 132. Mona Lisa N.V. Intrauterine Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Mona Lisa N.V. Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Mona Lisa N.V. Recent Developments
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Intrauterine Contraceptive Distributors List
    Table 138. Intrauterine Contraceptive Customers List
    Table 139. Intrauterine Contraceptive Market Trends
    Table 140. Intrauterine Contraceptive Market Drivers
    Table 141. Intrauterine Contraceptive Market Challenges
    Table 142. Intrauterine Contraceptive Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Intrauterine Contraceptive Product Picture
    Figure 3. Global Intrauterine Contraceptive Market Share by Type in 2021 & 2028
    Figure 3. Nonhormonal Intrauterine Contraceptive Devices Product Picture
    Figure 4. Hormonal Intrauterine Contraceptive Devices Product Picture
    Figure 5. Global Intrauterine Contraceptive Market Share by Application in 2021 & 2028
    Figure 6. Hospitals
    Figure 7. Community Health Care Centers
    Figure 8. Others
    Figure 9. Intrauterine Contraceptive Report Years Considered
    Figure 10. Global Intrauterine Contraceptive Sales 2017-2028 (K Units)
    Figure 11. Global Intrauterine Contraceptive Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Intrauterine Contraceptive Revenue 2017-2028 (US$ Million)
    Figure 13. Global Intrauterine Contraceptive Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Intrauterine Contraceptive Sales Market Share by Region (2017-2022)
    Figure 15. Global Intrauterine Contraceptive Sales Market Share by Region (2023-2028)
    Figure 16. North America Intrauterine Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Intrauterine Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Intrauterine Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Intrauterine Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Intrauterine Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Intrauterine Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Intrauterine Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Intrauterine Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Intrauterine Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Intrauterine Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Intrauterine Contraceptive Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Intrauterine Contraceptive in the World: Market Share by Intrauterine Contraceptive Revenue in 2021
    Figure 28. Global Intrauterine Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Intrauterine Contraceptive Sales Market Share by Type (2017-2028)
    Figure 30. Global Intrauterine Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 31. Global Intrauterine Contraceptive Sales Market Share by Application (2017-2028)
    Figure 32. Global Intrauterine Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 33. North America Intrauterine Contraceptive Sales Market Share by Type (2017-2028)
    Figure 34. North America Intrauterine Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 35. North America Intrauterine Contraceptive Sales Market Share by Application (2017-2028)
    Figure 36. North America Intrauterine Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 37. North America Intrauterine Contraceptive Sales Share by Country (2017-2028)
    Figure 38. North America Intrauterine Contraceptive Revenue Share by Country (2017-2028)
    Figure 39. U.S. Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Intrauterine Contraceptive Sales Market Share by Type (2017-2028)
    Figure 42. Europe Intrauterine Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Intrauterine Contraceptive Sales Market Share by Application (2017-2028)
    Figure 44. Europe Intrauterine Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Intrauterine Contraceptive Sales Share by Country (2017-2028)
    Figure 46. Europe Intrauterine Contraceptive Revenue Share by Country (2017-2028)
    Figure 47. Germany Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 48. France Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Intrauterine Contraceptive Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Intrauterine Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Intrauterine Contraceptive Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Intrauterine Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Intrauterine Contraceptive Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Intrauterine Contraceptive Revenue Share by Region (2017-2028)
    Figure 58. China Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 61. India Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Intrauterine Contraceptive Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Intrauterine Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Intrauterine Contraceptive Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Intrauterine Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Intrauterine Contraceptive Sales Share by Country (2017-2028)
    Figure 73. Latin America Intrauterine Contraceptive Revenue Share by Country (2017-2028)
    Figure 74. Mexico Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Intrauterine Contraceptive Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Intrauterine Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Intrauterine Contraceptive Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Intrauterine Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Intrauterine Contraceptive Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Intrauterine Contraceptive Revenue Share by Country (2017-2028)
    Figure 83. Turkey Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Intrauterine Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 86. Intrauterine Contraceptive Value Chain
    Figure 87. Intrauterine Contraceptive Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global Nelfinavir Market Insights Forecast to 2028
Global Nelfinavir Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-25I7469
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Mifepristone Market Insights and Forecast to 2028
Global Mifepristone Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-19O7878
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Misoprostol Market Insights and Forecast to 2028
Global Misoprostol Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-24D7622
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Clomifene Market Insights and Forecast to 2028
Global Clomifene Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-20N7761
Tue May 03 00:00:00 UTC 2022

Add to Cart